John Zentgraf

Currently, Mr. Zentgraf is the COO of NitriCap Medical Inc. developing a new antimicrobial technology for use with in-dwelling catheters. Mr. Zentgraf has 40+ years medical device industry experience including 21 years with Guidant where he led a team of 1,300 engineers and scientists through all phases of implantable product development, basic and applied research, and advanced technology development.

Mr. Zentgraf is an experienced entrepreneur, co-founding Phraxis Inc, Abilitech Medical, and Neochord Inc, and leading products through regulatory approval in the United States and Europe.

Mr. Zentgraf has extensive experience in analyzing emerging clinical technology, defining product requirements, executing design-control development, building FDA-compliant quality systems, and contract manufacturing design transfer process.